Evidence map›Paper›PMID 35832850›Full record

ArticleBioMed research international2022

Antidiabetic Effect of

Madhukar Saxena, S Venkatesa Prabhu, M Mohseen, Amit Kumar Pal, Saud Alarifi, Neelam Gautam, Hemalatha Palanivel

RetractedOpen access · hybridAbstract readRetracted Publication
PubMed Full text at PMC Publisher
In one paragraph

Article in BioMed research international, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Retracted: Antidiabetic Effect ofBioMed research international · 2024
    Article
  2. Article
4 · The record

Corrections and comments

  • Retraction · 2024-01-09Concerns/Issues about Data · Concerns/Issues about Results and/or Conclusions · Concerns/Issues about Referencing/Attributions · Concerns/Issues about Peer Review · Investigation by Journal/Publisher · Investigation by Third Party · Paper Mill · Computer-Aided Content or Computer-Generated Content · Unreliable Results and/or Conclusions ·
  • Retracted
5 · Who and what money

Authors and funding

7 authors at 4 institutions in 4 countries.

Madhukar SaxenaDepartment of Biotechnology, Babasaheb Bhimrao Ambedkar University, Lucknow 226025, India.ORCID https://orcid.org/0000-0001-7801-3715
S Venkatesa PrabhuCenter of Excellence for Bioprocess and Biotechnology, Department of Chemical Engineering, College of Biological and Chemical Engineering, Addis Ababa Science and Technology University, Addis Ababa, Ethiopia.
M MohseenDepartment of Toxicology and Pharmacology, Institute for Industrial Research & Toxicology, UPSIDC, Ghaziabad 201302, India.ORCID https://orcid.org/0000-0003-4748-2919
Amit Kumar PalDepartment of Toxicology and Pharmacology, Institute for Industrial Research & Toxicology, UPSIDC, Ghaziabad 201302, India.
Saud AlarifiDepartment of Zoology, College of Science, King Saud University, PO Box 2455, Riyadh 11451, Saudi Arabia.
Neelam GautamDepartment of Biological Sciences, Sungkyunkwan University, Jangan-Gu, Suwon, 16419 Gyeonggi-Do, Republic of Korea.
Hemalatha PalanivelCenter of Excellence for Bioprocess and Biotechnology, Department of Biotechnology, College of Biological and Chemical Engineering, Addis Ababa Science and Technology University, Addis Ababa, Ethiopia.ORCID https://orcid.org/0000-0002-7170-756X
Addis Ababa Science and Technology University · ETBabasaheb Bhimrao Ambedkar University · INKing Saud University · SASungkyunkwan University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To date, there is no satisfactory and effective therapy available to cure type 2 diabetes mellitus (T2DM). This present work is focused on plant extracts and the effect of saroglitazar and TET genes on oxidative stress and inflammation in vitro adipocytes. Aqueous extracts of

Indexed as

Diabetes Mellitus, ExperimentalDiabetes Mellitus, Type 2Momordica charantiaTamarindusAdipocytesAnimalsBlood GlucoseDown-RegulationGene ExpressionGlucoseHypoglycemic AgentsInflammationLipoproteins, LDLPhenylpropionatesPlant ExtractsPyrrolesBlood GlucoseGlucoseHypoglycemic AgentsLipoproteins, LDLPhenylpropionatesPlant ExtractsPyrrolessaroglitazar

Identifiers

PMID35832850
PMCPMC9273433
OpenAlexW4283818130

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.